syringaresinol has been researched along with isoliquiritigenin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awale, S; Esumi, H; Kadota, S; Li, F; Onozuka, H; Tezuka, Y | 1 |
| Awale, S; Kadota, S; Li, F; Tezuka, Y | 1 |
| Awale, S; Dang, PH; Nguyen, HX; Nguyen, KDH; Nguyen, MTT; Nguyen, NT | 1 |
| Kishore, N; Kumar, P; Shanker, K; Verma, AK | 1 |
1 review(s) available for syringaresinol and isoliquiritigenin
| Article | Year |
|---|---|
Human disorders associated with inflammation and the evolving role of natural products to overcome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Products; Cardiovascular Diseases; Humans; Inflammation; Neoplasms; Skin Diseases | 2019 |
3 other study(ies) available for syringaresinol and isoliquiritigenin
| Article | Year |
|---|---|
Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Necrosis; Nutritional Requirements; Pancreatic Neoplasms; Phytotherapy; Plant Extracts; Propolis; Sensitivity and Specificity | 2008 |
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
Topics: Animals; Brazil; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavanones; Flavonoids; HeLa Cells; Humans; Inhibitory Concentration 50; Mice; Molecular Structure; Neoplasms; Propolis; Stereoisomerism; Structure-Activity Relationship | 2008 |
Phytochemical and cytotoxic studies on the leaves of Calotropis gigantea.
Topics: Antineoplastic Agents, Phytogenic; Calotropis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lignans; Molecular Structure; Phytochemicals; Plant Leaves; Structure-Activity Relationship | 2017 |